Navigation Links
Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Date:4/26/2012

ATLANTA, April 26, 2012 /PRNewswire/ -- UCB today announced interim results from the VITOBA™ (VImpaT® added to One Baseline AED) study, which showed that patients with less refractory partial-onset seizures treated with Vimpat® (lacosamide) C-V as add-on to monotherapy experienced seizure reduction.  These data were presented today at the 64th annual meeting of the American Academy of Neurology (AAN) in New Orleans. 

VITOBA™ is a six-month prospective, non-interventional study of the efficacy, safety and tolerability of lacosamide when added to a single AED in patients with partial-onset seizures.  The study has a planned enrollment of 500 adult patients. This interim analysis included efficacy data for 99 patients and safety data for 109 patients.

The patient population in VITOBA™ reflects epilepsy patients treated in routine clinical practice. The majority of patients (73.4 percent) had received only 1-3 AEDs since diagnosis. The mean lacosamide maintenance dose was 250mg/day and the median was 200mg/day.

Compared to the overall VITOBA™ study population, patients treated with only one lifetime AED experienced the greatest benefit from add-on therapy with lacosamide:

  • 86.7 percent showed a 50 percent or greater reduction in seizure frequency (vs. 77.8 percent of the overall study population)
  • 80 percent showed a more than 75 percent or greater reduction in seizure frequency (vs. 64.6 percent of the overall study population)
  • 66.7 percent of those with a history of one lifetime AED experienced seizure freedom (vs. 43.4 percent of the overall study population)

Treatment emergent adverse events (TEAEs) included fatigue (11.9 percent), dizziness (10.1 percent) and convulsion (5.5 percent).

"While preliminary, this interim analysis is noteworthy because it reflects a real-worl
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Utah , Aug. 29, 2014  BC Technical, ... has acquired Polaris Medical Imaging, a leader in sales, ... This strategic acquisition allows BC Technical to continue to ... specifically within MR and CT modalities. ... service," said Mark Alvarez , president and CEO ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
(Date:8/29/2014)... 29, 2014 Diseases largely eradicated in ... are returning. Measles was declared eliminated in 2000, yet ... of August 15—the highest incidence in 20 years. In ... declared whooping cough a problem of "epidemic proportions." ... and dying from these preventable diseases—in part because some ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... (OMX Nordic: ACTI) presented,pre-clinical results for the ... League Against Rheumatism, <a target="_blank" href=,"http://www.eular.org/">www.eular.org ... data presented show that I-3D has a,significant ... model for rheumatoid arthritis (RA)", commented Sven,Andréasson, ...
... Percent Fewer RA Patients,Reported Job Loss When ... Alone, BARCELONA, Spain, June 15, 2007 /PRNewswire-FirstCall/ ... most common causes of,disability in the Western ... arthritis (RA) patients treated with Abbott's HUMIRA(R),(adalimumab) ...
Cached Medicine Technology:New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7
(Date:8/30/2014)... (PRWEB) August 30, 2014 Insomnia causes disturbances ... listeners understand how they unknowingly developed insomnia and the steps ... nights during. Tune in to the show at this ... show airs live on August 30, and will be podcasted ... on programming, go to DrCarolFrancisTalkRadio.com. , "Insomnia causes ...
(Date:8/30/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... broken bones or other orthopedic trauma shops around for additional ... patients and patients who had used narcotic painkillers previously were ... lead author Dr. Brent Morris, a shoulder and neck surgeon ... doctors aren,t talking to one another about the painkiller needs ...
(Date:8/30/2014)... 2014 Hastings and Hastings, a qualified ... throughout Arizona is pleased to report having saved a ... example among many cases where Hastings and Hastings has ... retain a greater portion of their settlement or recovery. ... a positive solution for Arizona car accident victims is ...
(Date:8/30/2014)... a plant-based medication commonly used to treat gout, ... in reducing potential complications from this type of ... gastrointestinal adverse effects, according to a study published ... released early online to coincide with its presentation ... Common complications after cardiac surgery include postpericardiotomy syndrome ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "My ... sleep knowing that, at any moment, her fever might ... order to keep me well aware of how she ... developed the TEMP ALARM to continuously monitor a child's ... develops a fever. This ensures that prompt medical care ...
Breaking Medicine News(10 mins):Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2
... Earnings Per Share of $0.032008 Nexavar Net Sales of $678 ... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... quarter 2008. For the full year, Onyx recorded net ... with a net loss of $34.2 million, or $0.67 per ...
... (OTC Bulletin Board: EFSF) an emerging healthcare consumer products ... nutraceutical products, today announced that Martin Schmieg, current President ... CEO of eFoodSafety.com, has purchased stock in the open ... shares in the open market on February 23, 2009, ...
... VERNON, Wash., and LINCOLN, Neb., Feb. 23 ... leader in risk and disease analytic software designed ... oral disease, today announced a cooperation agreement with ... provider of dental practice management software running on ...
... , Inc. announced today that,Daniel P. Amos, Chairman and ... of $2.8 million that he earned based on achievement ... proposal,recognizing that, although Aflac delivered a strong operating performance ... price given the current,turbulence in the stock markets. , ...
... intake of calcium appear to have a lower risk of ... intakes have lower risks of colorectal cancer and other cancers ... February 23 issue of Archives of Internal Medicine , ... known to benefit bone health, according to background information in ...
... PARK, N.C., Feb. 23 The Clearinghouse on Male ... was launched today. The Web site is designed to ... male circumcision in HIV prevention. The Clearinghouse was initiated ... Nations Programme on HIV/AIDS (UNAIDS), the AIDS Vaccine Advocacy ...
Cached Medicine News:Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 2Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 3Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 4Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 5Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 6Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 7Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 8Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 9Health News:Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results 10Health News:eFoodSafety.com Announces Open Market Stock Purchase by Management 2Health News:PreViser Corporation and MacPractice Announce Cooperation Agreement 2Health News:Aflac Chairman & CEO Will Forgo 2008 Bonus of $2.8 Million 2Health News:Calcium associated with lower risk of cancer in women 2Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 2Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 3Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 4Health News:Clearinghouse on Male Circumcision for HIV Prevention Web Site Launched 5
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... ergonomic solution and best value in high ... action and ultra lightweight design reduce hand ... with long, lever tip ejector , Color ... universal tips or for greater performance use ...
... BioControl multichannel has the same ... channel model. The same universal ... and five single channel tip ... a recharge and storage stand ...
Medicine Products: